Stock comparison
AbbVie
ABBV$488.55BHealthcare Market cap, Sector
Biogen
BIIB$33.35BHealthcare Market cap, Sector
AbbVie
ABBV 70 BIIB
Based on the combined fit scores from all four strategies. The breakdown by strategy is below.
Fit scores by strategy
Side-by-side metrics
| Metric | ABBV | BIIB |
|---|---|---|
| Market cap | Winner: $488.55B | $33.35B |
| P/E (TTM) | 102.5x | 21.2x Winner |
| EV/EBIT | 52.2x | 17.3x Winner |
| ROIC (TTM) |
Where each one wins
The metrics with the widest gap between the two, biggest differences first.
ABBV leads on
- Revenue CAGR 5y1.75%vs -2.78%+163%
- Debt / Equity-vs 0.4x+102%
- Dividend yield3.08%vs 0.0%+100%
- Market cap$488.55Bvs $33.35B+93%
BIIB leads on
More like ABBV
More like BIIB
Related on invest-like
For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.